 |
ArchiveHigh-Beta Stocks Coming Back to Earth, Fast (FFIV, XLNX, UNH, MS, DDS, MNKD)Posted by Geoff Seiler at 4:48PM on January 20th
Stocks fell on the day, with the Nasdaq once again leading the market lower. High-beta stocks that had been market leaders have been hit particularly hard, and this very well could be beginning of the pullback we said we’ve been…  Majority of Hedge Fund Managers Bullish on 2011 (MCP, MNKD, GM, SHZ, RLD)Posted by Geoff Seiler at 4:39PM on December 28th
Stocks shrugged off some lackluster economic data to register another mixed day. The market continues to hold steady as 2010 comes to a close, and investors appear to be getting more bullish for 2011, with 46% of hedge fund managers… Volume Hunter: Biotech (MELA, OREX, VVUS, ARNA, CYPB, MNKD, DSCO, NVAX)Posted by Jason Smith at 10:41AM on December 15th
There has been plenty of FDA-driven action in the biotech sector of late, providing ample opportunity for active traders to capitalize on momentum trades. In November, a seemingly negative FDA staff review was followed by a surprise panel vote in… Fed, Economy Spell Good Recipe for Stocks (BBY, FDS, SAFM, HCP, MNKD)Posted by Geoff Seiler at 5:09PM on December 14th
A strong retail sales number trumped a poor report from Best Buy (BBY) to lift stocks initially, but for a second-straight day, equities retreated in late afternoon trading. However, after a brief dip into the red, the major market averages were… Merck Hikes Diabetes Exposure Via Acquisition (MRK, JNJ, DEPO, ARRY, MNKD, SPEX, BIOD, AMLN, GNBT, ALKS, LLY, ARNA)Posted by Jason Smith at 11:39AM on December 2nd
Pharmaceutical giant Merck (MRK) agreed to purchase Beverly, Massachusetts-based insulin maker SmartCells for as much as $500 million, boosting the firm’s exposure the diabetes segment, which generated $2.58 billion in 2009 revenue. Miller Tabak portfolio manager Les Funtleyder told Bloomberg, “We… Biotech Shares Pump Up The Volume (ONXX, MNTA, DNDN, ARNA, VVUS, JAZZ, MNKD, CYTX)Posted by Owen Vater at 11:16AM on July 26th
Recently we’ve been directing investors’ attention to volume spikes as a means of identifying the most tradable stocks in volatile equity segments. So often do biotech shares “float” in either direction on relatively sparse news that relative volume is often… Volume Hunter: Biotech (VVUS, OREX, ARNA, GILD, SOMX, POZN, BPAX, MNKD)Posted by Owen Vater at 11:08AM on July 16th
The biotech sector is among the most volatile on Wall Street, and as such it is a favorite among active traders. On a given trading day there’s bound to be a small-cap awaiting FDA results, news of a promising partnership,… Select Healthcare Stocks Float Higher Amid Broad Sell-Off (OSIR, NBS, CUR, KOOL, GERN, CPIX, OMER, DRRX, MIPI, MNKD)Posted by Jason Smith at 2:58PM on June 24th
Various segments of the healthcare industry staged a low-volume rally on Thursday as the major market benchmarks traded in the red. As a whole, the Stem Cell Stocks Index is ahead by 3% for the session as Osiris Therapeutics (OSIR) and Neostem (NBS) soar… Sharp Rebound for MannKind, Generex (GNBT, MNKD, SPEX, AMLN, NVO, ARRY)Posted by Jason Smith at 1:35PM on March 23rd
Shares of Valencia, California-based Mannkind Corp (MNKD) are rebounding sharply after two days of declines in a recent downtrend spurred by the FDA’s request for additional information related to the company’s Afrezza inhaled insulin. The stock remains off by -10% over… Home Diagnostics Buyout Powers Diabetes Segment (HDIX, ARRY, NVO, GNBT, AMLN, MNKD)Posted by Jason Smith at 12:03PM on February 3rd
Home Diagnositics (HDIX) is soaring today after the company announced a definitive merger agreement with Nipro Corporation. Nipro will pay $11.50 in cash per Home Diagnostics share or $215 million for the company in a two-step acquisition, which is set to…  |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |